Reduced Selenium-Binding Protein 1 in Breast Cancer Correlates with Poor Survival and Resistance to the Anti-Proliferative Effects of Selenium

• Sheng Zhang,

  Affiliation Molecular Surgeon Research Center, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Feng Li,

  Affiliation Molecular Surgeon Research Center, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Mamoun Younes,

  Affiliation Department of Pathology and Laboratory Medicine, University of Texas Medical School at Houston, Houston, Texas, United States of America

  ⨯
• Hao Liu,

  Affiliation Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Changyi Chen,

  Affiliation Molecular Surgeon Research Center, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Qizhi Yao

  * E-mail: qizhiyao@bcm.edu

  Affiliations Molecular Surgeon Research Center, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, United States of America, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯